clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00492999 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | United States of America | Q30 |
P582 | end time | 2020-05-01 | |
P921 | main subject | rectum adenocarcinoma | Q18554959 |
P4135 | maximum age | 120 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 64 | |
P4844 | research intervention | fluorouracil | Q238512 |
(RS)-cyclophosphamide | Q408524 | ||
irinotecan | Q412197 | ||
calcium oxalate | Q412399 | ||
leucovorin calcium | Q27077063 | ||
P6153 | research site | Memorial Sloan Kettering Cancer Center | Q1808012 |
P580 | start time | 2007-05-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | A Phase II Study of the Rate of Conversion to Complete Resection in Patients With Initially Inoperable Hepatic-Only Metastases From Colorectal Cancer After Treatment With Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Best Systemic Chemotherapy |
Search more.